Cholinergic lesions by 192 IgG-saporin and short-term recognition memory: role of the septohippocampal projection

Neuroscience. 1995 May;66(1):101-14. doi: 10.1016/0306-4522(94)00603-3.

Abstract

Two experiments examined the effects of cholinergic basal forebrain lesions by intraventricular and intrahippocampal infusions of the immunotoxin 192 IgG-saporin on recognition memory in an operant delayed-non-matching-to-position task in rats. Intraventricular infusions produced extensive reductions in cortical and hippocampal choline acetyltransferase activity in the first experiment. Behaviourally, a mixed delay-dependent/independent accuracy deficit and increased biased responding was observed post-lesioning. Thus, both mnemonic as well as non-mnemonic processes were affected by the lesion. This performance deficit was indistinguishable from the impairment induced by acute intraventricular injections of the choline uptake inhibitor hemicholinium-3, which suggests that cholinergic damage induced by 192 IgG-saporin disrupted performance. In the second experiment more discrete intrahippocampal 192 IgG-saporin lesions were made, which reduced hippocampal choline acetyltransferase activity about 57%, although this reduction was not as extensive as following intraventricular injections. Although intrahippocampal lesions also impaired non-matching accuracy, this effect failed to reach significance during most stages of the experiment. Scopolamine just failed to significantly impair (P = 0.053) performance in hippocampal lesioned rats more than in controls. The nicotinic antagonist mecamylamine did not affect the lesion-induced changes in performance. These results suggest that the cholinergic basal forebrain, including the septohippocampal system, is important for the mediation of recognition memory, and muscarinic receptor-mediated mechanisms may be of greater importance than alterations of nicotinic receptor-mediated processes in the septohippocampal system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholinesterase / metabolism
  • Animals
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / toxicity*
  • Autonomic Nervous System Diseases / chemically induced*
  • Autonomic Nervous System Diseases / pathology
  • Choline O-Acetyltransferase / metabolism
  • Cholinergic Agents / administration & dosage
  • Cholinergic Agents / toxicity*
  • Cognition Disorders / chemically induced*
  • Conditioning, Operant / drug effects
  • Glutamate Decarboxylase / metabolism
  • Hippocampus / cytology
  • Hippocampus / enzymology
  • Hippocampus / physiology*
  • Immunotoxins / administration & dosage
  • Immunotoxins / toxicity*
  • Injections
  • Injections, Intraventricular
  • Male
  • Memory Disorders / chemically induced*
  • N-Glycosyl Hydrolases
  • Neural Pathways / cytology
  • Neural Pathways / physiology
  • Parasympathetic Nervous System / physiology*
  • Prosencephalon / cytology
  • Prosencephalon / enzymology
  • Prosencephalon / physiology*
  • Rats
  • Ribosome Inactivating Proteins, Type 1
  • Saporins
  • Scopolamine / pharmacology

Substances

  • 192 IgG-saporin
  • Antibodies, Monoclonal
  • Cholinergic Agents
  • Immunotoxins
  • Ribosome Inactivating Proteins, Type 1
  • Scopolamine
  • Choline O-Acetyltransferase
  • Acetylcholinesterase
  • N-Glycosyl Hydrolases
  • Saporins
  • Glutamate Decarboxylase